Mélanie Bruchard

6.0k total citations · 3 hit papers
31 papers, 3.9k citations indexed

About

Mélanie Bruchard is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mélanie Bruchard has authored 31 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Mélanie Bruchard's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (9 papers) and IL-33, ST2, and ILC Pathways (8 papers). Mélanie Bruchard is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (9 papers) and IL-33, ST2, and ILC Pathways (8 papers). Mélanie Bruchard collaborates with scholars based in France, United States and Netherlands. Mélanie Bruchard's co-authors include François Ghiringhelli, Fanny Chalmin, Cédric Rébé, Lionel Apétoh, Grégoire Mignot, Angélique Chevriaux, Frédérique Végran, Sylvain Ladoire, Julie Vincent and François Martin and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Mélanie Bruchard

31 papers receiving 3.8k citations

Hit Papers

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid... 2010 2026 2015 2020 2010 2012 2016 250 500 750

Peers

Mélanie Bruchard
Ann Ager United Kingdom
Ezio Bonvini United States
Xue‐Zhong Yu United States
Melvyn T. Chow Australia
Jianxun Song United States
Mélanie Bruchard
Citations per year, relative to Mélanie Bruchard Mélanie Bruchard (= 1×) peers Fanny Chalmin

Countries citing papers authored by Mélanie Bruchard

Since Specialization
Citations

This map shows the geographic impact of Mélanie Bruchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Bruchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Bruchard more than expected).

Fields of papers citing papers by Mélanie Bruchard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Bruchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Bruchard. The network helps show where Mélanie Bruchard may publish in the future.

Co-authorship network of co-authors of Mélanie Bruchard

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Bruchard. A scholar is included among the top collaborators of Mélanie Bruchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Bruchard. Mélanie Bruchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richard, Corentin, Étienne Humblin, Sandy Chevrier, et al.. (2025). The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs. Cellular and Molecular Immunology. 22(5). 541–556. 7 indexed citations
2.
Ghiringhelli, François, et al.. (2024). Natural Killer cells at the frontline in the fight against cancer. Cell Death and Disease. 15(8). 614–614. 44 indexed citations
3.
Racoeur, Cindy, Jingxuan Shan, S Ghione, et al.. (2023). GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC. Cancers. 15(12). 3129–3129. 6 indexed citations
4.
Bruchard, Mélanie, Caroline Truntzer, Elise Ballot, et al.. (2022). Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nature Immunology. 23(2). 262–274. 62 indexed citations
5.
Bruchard, Mélanie & Hergen Spits. (2022). The role of ILC subsets in cancer. Seminars in Immunology. 61-64. 101654–101654. 13 indexed citations
6.
Richard, Corentin, Sandy Chevrier, Sophie Lemoine, et al.. (2021). The Tumor Microenvironment Impairs Th1 IFNγ Secretion through Alternative Splicing Modifications of Irf1 Pre-mRNA. Cancer Immunology Research. 9(3). 324–336. 13 indexed citations
7.
Rao, Anna, Otto Strauß, Efthymia Kokkinou, et al.. (2020). Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs. Nature Communications. 11(1). 2049–2049. 50 indexed citations
8.
Bruchard, Mélanie & François Ghiringhelli. (2019). Deciphering the Roles of Innate Lymphoid Cells in Cancer. Frontiers in Immunology. 10. 656–656. 57 indexed citations
9.
Fergusson, Joannah R., Michael D. Morgan, Mélanie Bruchard, et al.. (2019). Maturing Human CD127+ CCR7+ PDL1+ Dendritic Cells Express AIRE in the Absence of Tissue Restricted Antigens. Frontiers in Immunology. 9. 2902–2902. 28 indexed citations
10.
Bal, Suzanne M., Jochem H. Bernink, Maho Nagasawa, et al.. (2016). IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nature Immunology. 17(6). 636–645. 371 indexed citations breakdown →
11.
Bruchard, Mélanie, Cédric Rébé, Valentin Dérangère, et al.. (2015). The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nature Immunology. 16(8). 859–870. 299 indexed citations
12.
Bruchard, Mélanie & François Ghiringhelli. (2014). Modulation de l’immunosuppression par des chimiothérapies et identification de nouvelles cibles thérapeutiques. Bulletin du Cancer. 101(6). 605–607. 13 indexed citations
13.
Berger, Hélène, Frédérique Végran, Federica Gilardi, et al.. (2013). SOCS3 Transactivation by PPARγ Prevents IL-17–Driven Cancer Growth. Cancer Research. 73(12). 3578–3590. 47 indexed citations
14.
Bugaut, Hélène, Mélanie Bruchard, Hélène Berger, et al.. (2013). Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells. PLoS ONE. 8(6). e65181–e65181. 90 indexed citations
15.
Ghiringhelli, François, Mélanie Bruchard, & Lionel Apétoh. (2013). Immune effects of 5-fluorouracil. OncoImmunology. 2(3). e23139–e23139. 38 indexed citations
16.
Hervieu, Alice, Cédric Rébé, Frédérique Végran, et al.. (2012). Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth. Journal of Investigative Dermatology. 133(2). 499–508. 77 indexed citations
17.
Bruchard, Mélanie, Grégoire Mignot, Valentin Dérangère, et al.. (2012). Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth. Nature Medicine. 19(1). 57–64. 615 indexed citations breakdown →
18.
Chalmin, Fanny, Grégoire Mignot, Mélanie Bruchard, et al.. (2012). Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression. Immunity. 36(3). 362–373. 269 indexed citations
19.
Vincent, Julie, Grégoire Mignot, Fanny Chalmin, et al.. (2010). 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity. Cancer Research. 70(8). 3052–3061. 969 indexed citations breakdown →
20.
Ladoire, Sylvain, Laurent Arnould, Grégoire Mignot, et al.. (2010). Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 125(1). 65–72. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026